Product Images Topiramate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Topiramate NDC 68071-4877 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pdp - 68071 4877 3

pdp - 68071 4877 3

This is a description of a Topiramate medication bottle containing 30 tablets of 100mg each. It shows the Manufacturer's National Drug Code (MFR), the National Drug Code (NDC) for the lot number, and the Expiration Date. The product is a white round pill with "ZD 14" on one side and "000000" on the other. The bottle warns to keep this product out of the reach of children and store it at controlled temperature between 68 to 77 degrees Fahrenheit. The label also recommends calling a doctor for any medical advice and reporting any side effects to FDA at 1-800-FDA-1088.*

Structured product formula for Topiramate - 971eaaa1 517d 455f b883 46210de3be3d 01

Structured product formula for Topiramate - 971eaaa1 517d 455f b883 46210de3be3d 01

Structured product formula for Topiramate - 971eaaa1 517d 455f b883 46210de3be3d 02

Structured product formula for Topiramate - 971eaaa1 517d 455f b883 46210de3be3d 02

The text appears to be a caption or label for a graph displaying "Cumulative Rates for Time to First Seizure" using Kaplan Meier estimates. The graph compares the rates between two groups, one group taking topiramate at 50mg/day and the other group taking topiramate at 400mg/day. The x-axis indicates time in days with a range from 0 to 404.*

Topiramate Tablets USP - 971eaaa1 517d 455f b883 46210de3be3d 03

Topiramate Tablets USP - 971eaaa1 517d 455f b883 46210de3be3d 03

This is a table showing the reduction in migraine headache frequency from baseline to the double-blind phase in studies 10 and 11 for both adults and adolescents. The table includes data for the medication topiramate at three different dosages (0mg/day, 100mg/day, and 200mg/day) as well as a placebo group. There are also statistical significance levels provided for the differences in reduction rates between the groups.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.